Neurocrine Biosciences, Inc. is a California-based biopharmaceutical company that develops treatments for neurological, endocrine, and psychiatric disorders. Its filings show it lobbies Congress on health-related topics like Medicare and Medicaid, federal budget and appropriations, prescription drug pricing and payment reform, innovation including the Inflation Reduction Act, and telehealth and mental health issues. It reported $320,000 in lobbying since 4 filings and used the firm Tarplin, Downs & Young.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
ELIZABETH T MURRAY
The latest disclosures for this client.
TARPLIN, DOWNS & YOUNG, LLC
Q3TARPLIN, DOWNS & YOUNG, LLC
Q2The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
TARPLIN, DOWNS & YOUNG, LLC
EMILY H MURRY
TARPLIN, DOWNS & YOUNG, LLC
JENNIFER B YOUNG
TARPLIN, DOWNS & YOUNG, LLC
MEG JOSEPH
TARPLIN, DOWNS & YOUNG, LLC
mr PARICK BRAERTON CARROLL
TARPLIN, DOWNS & YOUNG, LLC
PAMELA SMITH
TARPLIN, DOWNS & YOUNG, LLC
RAISSA H DOWNS
TARPLIN, DOWNS & YOUNG, LLC
JEFF RECZEK
TARPLIN, DOWNS & YOUNG, LLC
TARPLIN, DOWNS & YOUNG, LLC
Q1TARPLIN, DOWNS & YOUNG, LLC
Q4TARPLIN, DOWNS & YOUNG, LLC
Q3TARPLIN, DOWNS & YOUNG, LLC
Q2TARPLIN, DOWNS & YOUNG, LLC
Q1